De-Sheng Weng

1.9k total citations
33 papers, 1.6k citations indexed

About

De-Sheng Weng is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, De-Sheng Weng has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 21 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in De-Sheng Weng's work include Immune Cell Function and Interaction (15 papers), Immunotherapy and Immune Responses (13 papers) and Cancer Immunotherapy and Biomarkers (12 papers). De-Sheng Weng is often cited by papers focused on Immune Cell Function and Interaction (15 papers), Immunotherapy and Immune Responses (13 papers) and Cancer Immunotherapy and Biomarkers (12 papers). De-Sheng Weng collaborates with scholars based in China, United States and Canada. De-Sheng Weng's co-authors include Jian‐Chuan Xia, Jing-Jing Zhao, Qiu-Zhong Pan, Qi-Jing Wang, Ke Pan, Xiao Hai Li, Shan-Shan Jiang, Min-Shan Chen, Chang-Long Chen and Xiaofei Zhang and has published in prestigious journals such as Scientific Reports, Clinical Cancer Research and Stem Cells.

In The Last Decade

De-Sheng Weng

33 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
De-Sheng Weng China 23 846 787 470 210 179 33 1.6k
Jing-Jing Zhao China 25 813 1.0× 786 1.0× 448 1.0× 244 1.2× 154 0.9× 37 1.5k
Long‐Yun Ye China 22 490 0.6× 613 0.8× 549 1.2× 384 1.8× 146 0.8× 49 1.5k
Hiromasa Kuroda Japan 20 573 0.7× 440 0.6× 466 1.0× 226 1.1× 83 0.5× 42 1.5k
Janelle Simon United States 11 727 0.9× 504 0.6× 993 2.1× 379 1.8× 132 0.7× 13 2.0k
Qihan Fu China 21 664 0.8× 371 0.5× 629 1.3× 518 2.5× 257 1.4× 44 1.5k
Derya Duranyıldız Türkiye 22 662 0.8× 282 0.4× 603 1.3× 294 1.4× 234 1.3× 85 1.4k
Ji Yuan Wu United States 21 666 0.8× 168 0.2× 712 1.5× 173 0.8× 256 1.4× 44 2.1k
Vera Levina United States 13 688 0.8× 178 0.2× 581 1.2× 296 1.4× 141 0.8× 18 1.1k
Maxime Meylan France 9 850 1.0× 700 0.9× 389 0.8× 231 1.1× 308 1.7× 24 1.4k
Chongbiao Huang China 26 765 0.9× 439 0.6× 824 1.8× 598 2.8× 261 1.5× 49 1.7k

Countries citing papers authored by De-Sheng Weng

Since Specialization
Citations

This map shows the geographic impact of De-Sheng Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by De-Sheng Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites De-Sheng Weng more than expected).

Fields of papers citing papers by De-Sheng Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by De-Sheng Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by De-Sheng Weng. The network helps show where De-Sheng Weng may publish in the future.

Co-authorship network of co-authors of De-Sheng Weng

This figure shows the co-authorship network connecting the top 25 collaborators of De-Sheng Weng. A scholar is included among the top collaborators of De-Sheng Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with De-Sheng Weng. De-Sheng Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Qian, Hao Hu, De-Sheng Weng, et al.. (2020). Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma. Journal of Hematology & Oncology. 13(1). 2–2. 51 indexed citations
2.
Pan, Qiu-Zhong, Qing Liu, Jing-Jing Zhao, et al.. (2020). CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma. Cancer Immunology Immunotherapy. 69(5). 825–834. 15 indexed citations
3.
Zhou, Zi-Qi, Jing-Jing Zhao, Qiu-Zhong Pan, et al.. (2019). PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer. Journal for ImmunoTherapy of Cancer. 7(1). 228–228. 27 indexed citations
4.
Zhao, Jing-Jing, Zi-Qi Zhou, Qiu-Zhong Pan, et al.. (2019). <p>IL-37 induces anti-tumor immunity by indirectly promoting dendritic cell recruitment and activation in hepatocellular carcinoma</p>. Cancer Management and Research. Volume 11. 6691–6702. 24 indexed citations
5.
Zhao, Jing-Jing, Chang-Long Chen, Hong-Xia Zhang, et al.. (2018). Clinical Effect of Adjuvant Cytokine-Induced Killer Cells Immunotherapy in Patients with Stage II-IVB Nasopharyngeal Carcinoma after Chemoradiotherapy: A propensity score analysis. Journal of Cancer. 9(22). 4204–4214. 4 indexed citations
6.
Zhu, Qian, Hao Hu, De-Sheng Weng, et al.. (2017). Pooled safety analyses of ALK-TKI inhibitor in ALK-positive NSCLC. BMC Cancer. 17(1). 412–412. 22 indexed citations
7.
Jiang, Long, De-Sheng Weng, Yuanfang Li, et al.. (2017). Immunization-based scores as independent prognostic predictors in soft tissue sarcoma patients. Journal of Cancer. 8(4). 606–616. 3 indexed citations
8.
Chen, Chang-Long, Qiu-Zhong Pan, Jing-Jing Zhao, et al.. (2016). PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma. OncoImmunology. 5(7). e1176653–e1176653. 51 indexed citations
9.
Zhang, Xiaofei, Jie Chao, Qiu-Zhong Pan, et al.. (2015). Overexpression of WWP1 Promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma. Oncotarget. 6(38). 40920–40933. 28 indexed citations
10.
Pan, Qiu-Zhong, Qi-Jing Wang, Ke Pan, et al.. (2015). A Nomogram for Predicting the Benefit of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Hepatocellular Carcinoma. Scientific Reports. 5(1). 9202–9202. 23 indexed citations
11.
Pan, Ke, Yong-Qiang Li, Jing-Jing Zhao, et al.. (2014). Clinical Activity of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Post-Mastectomy Triple-Negative Breast Cancer. Clinical Cancer Research. 20(11). 3003–3011. 77 indexed citations
12.
Pan, Qiu-Zhong, Ke Pan, Qi-Jing Wang, et al.. (2014). Annexin A3 as a Potential Target for Immunotherapy of Liver Cancer Stem-Like Cells. Stem Cells. 33(2). 354–366. 56 indexed citations
13.
Zhao, Jing-Jing, Qiu-Zhong Pan, Ke Pan, et al.. (2014). Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+ NK Cells. Scientific Reports. 4(1). 5177–5177. 93 indexed citations
14.
Lü, Lin, Ke Pan, Haixia Zheng, et al.. (2013). IL-17A Promotes Immune Cell Recruitment in Human Esophageal Cancers and the Infiltrating Dendritic Cells Represent a Positive Prognostic Marker for Patient Survival. Journal of Immunotherapy. 36(8). 451–458. 77 indexed citations
15.
Zhang, Fei, Yong-Qiang Li, Haixia Zheng, et al.. (2013). Safety of in vitro amplified HLA-haploidentical donor immune cell infusions for childhood malignancies. Chinese Journal of Cancer. 32(12). 661–666. 3 indexed citations
16.
Pan, Ke, Yong-Qiang Li, Li Xu, et al.. (2013). The Efficacy of Cytokine-Induced Killer Cell Infusion as an Adjuvant Therapy for Postoperative Hepatocellular Carcinoma Patients. Annals of Surgical Oncology. 20(13). 4305–4311. 68 indexed citations
17.
Zhao, Jing-Jing, Ke Pan, Qi-Jing Wang, et al.. (2013). Effect of anti-asthma Chinese medicine Chuankezhi on the anti-tumor activity of cytokine-induced killer cells. Chinese Journal of Cancer. 32(10). 553–60. 9 indexed citations
18.
Pan, Ke, Hui Wang, Wan-Li Liu, et al.. (2008). The pivotal role of p38 and NF-κB signal pathways in the maturation of human monocyte-derived dendritic cells stimulated by streptococcal agent OK-432. Immunobiology. 214(5). 350–358. 16 indexed citations
19.
Weng, De-Sheng, Jun Zhou, Ming Zhao, et al.. (2008). Minimally Invasive Treatment Combined With Cytokine-induced Killer Cells Therapy Lower the Short-term Recurrence Rates of Hepatocellular Carcinomas. Journal of Immunotherapy. 31(1). 63–71. 127 indexed citations
20.
Pan, Ke, Hui Wang, De-Sheng Weng, et al.. (2007). Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma. Cancer Letters. 261(2). 183–192. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jing-Jing Zhao Breakdown of academic impact, for papers by Long‐Yun Ye Breakdown of academic impact, for papers by Hiromasa Kuroda Breakdown of academic impact, for papers by Janelle Simon Breakdown of academic impact, for papers by Qihan Fu Breakdown of academic impact, for papers by Derya Duranyıldız Breakdown of academic impact, for papers by Ji Yuan Wu Breakdown of academic impact, for papers by Vera Levina Breakdown of academic impact, for papers by Maxime Meylan Breakdown of academic impact, for papers by Chongbiao Huang
Rankless by CCL
2026